Abstract: A display device includes: a base layer; a light emitting element on the base layer, and including a first electrode, an intermediate layer on the first electrode, and a second electrode on the intermediate layer; a pixel definition film on the first electrode, and having a light emitting opening exposing a portion of the first electrode; a separator on the pixel definition film, and disconnecting the second electrode; and an encapsulation layer on the pixel definition film, and including: a first encapsulation layer including a first sub-layer covering the separator, a second sub-layer on the first sub-layer, and a third sub-layer on the second sub-layer; a second encapsulation layer on the first encapsulation layer, and including an organic material; and a third encapsulation layer on the second encapsulation layer, and including an inorganic material. At least one of the first sub-layer or the second sub-layer includes an organic material.

Abstract: A display panel includes a transistor, a light emitting device electrically connected to the transistor, a connection wiring electrically connecting the transistor to the light emitting device and including side surfaces, a capping pattern disposed on the transistor and contacting at least a side surface among side surfaces, an upper insulating layer disposed on the transistor and including a first opening that overlaps the at least the side surface, and a pixel definition layer disposed on the upper insulating layer and covering the first opening of the upper insulating layer.

Abstract: A vehicle having a road surface recognition apparatus, may perform obtaining, by a controller, sound data for a sound detected by a sound detector while driving; obtaining, by the controller, driving data for driving information detected by a driving information detector; recognizing, by the controller, a type of road surface based on the obtained sound data and the obtained driving data; and controlling, by the controller, a traction control system based on information related to the recognized type of the road surface.

Abstract: A method for automatic speech recognition using joint acoustic echo cancellation, speech enhancement, and voice separation includes receiving, at a contextual frontend processing model, input speech features corresponding to a target utterance. The method also includes receiving, at the contextual frontend processing model, at least one of a reference audio signal, a contextual noise signal including noise prior to the target utterance, or a speaker embedding including voice characteristics of a target speaker that spoke the target utterance. The method further includes processing, using the contextual frontend processing model, the input speech features and the at least one of the reference audio signal, the contextual noise signal, or the speaker embedding vector to generate enhanced speech features.

Abstract: A cosmetic composition for deformed nail care, includes a fermented product of an extract extracted from a raw material comprising bellflower, licorice, and Korean angelica. The fermented product is a fermented product fermented with lactic acid bacteria. The raw material comprises 80 to 120 parts by weight of licorice and 80 to 120 parts by weight of Korean angelica based on 100 parts by weight of balloon flower.

Abstract: A support unit may include a plurality of heaters disposed in a matrix form in the support unit to heat a substrate, and a power supply unit for supplying power to the plurality of heaters, wherein a current applied to the plurality of heaters is controlled by switches connected to rows and columns of the matrix, respectively, and the switches connected to the rows of the matrix include first switches capable of controlling the current applied to the rows of the matrix and second switches connected in parallel with the first switches.

Abstract: Chimeric antigen receptor-transduced T cells (CAR-T cells) show a remarkable efficacy for some hematological malignancies. However, CAR targets are restricted to a few antigens primarily due to on-target off-tumor toxicities of CAR-T cells. Although several strategies were proposed to avoid on-target off-tumor toxicities, most of them use complicated designs including dual gene expression for specificity. In this study, we show that switchable CAR immune cells (e.g., CAR-T cells) with a tumor-targeting adaptor can mitigate on-target off-tumor toxicity against the tumor antigen that cannot be targeted with conventional CAR immune cells due to this toxicity, such as CD40 and CS1. Therefore, a switchable CAR system is a valuable tool to control CAR-T cell toxicity while maintaining therapeutic efficacy, which enables CAR anti-tumor target expansion.

Abstract: The present invention relates to a composition for preventing or treating liver disease, comprising icaritin and quercetin. It is ascertained that when icaritin and quercetin are used in combination rather than individually, the composition of the present invention has a superior effect of hepatic cell protection, and the optimal mixing ratio is derived, and it is also ascertained that the composition exhibits hepatoprotective action and does not induce toxicity in normal cells, and thus the present invention can be used as an active ingredient of a therapeutic agent for liver disease or a health functional food for preventing liver disease.

Abstract: The present disclosure relates to a novel compound for photodynamic therapy of cancer, a composition including the same, and a method for photodynamic therapy of cancer, and more specifically, a novel photosensitizer compound based on Nplmidazole having a C?S functional group introduced, a composition and sensor including the same and a method for photodynamic therapy using the same.

Abstract: A roll-bonded evaporator is formed from a first sheet and a second sheet roll bonded together in face to face relationship with a conductive heater located between the sheets. A refrigerant passageway system is formed in unwelded areas where the first and second sheets are not roll bonded to one another thereby defining a refrigerant channel, a refrigerant inlet and a refrigerant outlet. A heater is preferably formed with a first end and a second end located between the refrigerant inlet and the refrigerant outlet at a proximate end of the evaporator. Alternatively, the conductive heater is formed in a path having the second end located at the distal end of the evaporator and passing through the first sheet at the distal end.

Abstract: A roll-bonded evaporator is formed from a first sheet and a second sheet roll bonded together in face to face relationship with a conductive heater located between the sheets. A refrigerant passageway system is formed in unwelded areas where the first and second sheets are not roll bonded to one another thereby defining a refrigerant channel, a refrigerant inlet and a refrigerant outlet. A heater is preferably formed with a first end and a second end located between the refrigerant inlet and the refrigerant outlet at a proximate end of the evaporator. Alternatively, the conductive heater is formed in a path having the second end located at the distal end of the evaporator and passing through the first sheet at the distal end.

Abstract: A skin whitening method including: administering to a subject a cosmetic composition including a tranexamic acid-peptide having skin whitening activity selected from the group consisting of Tranexamil-AS, Tranexamil-AT, Tranexamil-AP, Tranexamil-GP, Tranexamil-ES, Tranexamil-KK, Tranexamil-HK, Tranexamil-MY, Tranexamil-GH, Tranexamil-MA, Tranexamil-AH, Tranexamil-CC, Tranexamil-SA, Tranexamil-WA, Tranexamil-WE, Tranexamil-KD, Tranexamil-NA, Tranexamil-TS, Tranexamil-SS, Tranexamil-EC, Tranexamil-TA, Tranexamil-PF, Tranexamil-VS, Tranexamil-VV, Tranexamil-VP, Tranexamil-AA, Tranexamil-PS, Tranexamil-HA, Tranexamil-GK, Tranexamil-KV, Tranexamil-AR, Tranexamil-RP, Tranexamil-PQ, Tranexamil-QG, Tranexamil-PP, Tranexamil-VR, Tranexamil-SV, Tranexamil-ET, Tranexamil-CG and Tranexamil-NT.

Abstract: A skin whitening method including: administering to a subject a cosmetic composition including a tranexamic acid-peptide having skin whitening activity selected from the group consisting of Tranexamil-AS, Tranexamil-AT, Tranexamil-AP, Tranexamil-GP, Tranexamil-ES, Tranexamil-KK, Tranexamil-HK, Tranexamil-MY, Tranexamil-GH, Tranexamil-MA, Tranexamil-AH, Tranexamil-CC, Tranexamil-SA, Tranexamil-WA, Tranexamil-WE, Tranexamil-KD, Tranexamil-NA, Tranexamil-TS, Tranexamil-SS, Tranexamil-EC, Tranexamil-TA, Tranexamil-PF, Tranexamil-VS, Tranexamil-VV, Tranexamil-VP, Tranexamil-AA, Tranexamil-PS, Tranexamil-HA, Tranexamil-GK, Tranexamil-KV, Tranexamil-AR, Tranexamil-RP, Tranexamil-PQ, Tranexamil-QG, Tranexamil-PP, Tranexamil-VR, Tranexamil-SV, Tranexamil-ET, Tranexamil-CG and Tranexamil-NT.

Abstract: The present invention relates to a hyaluronidase inhibitor containing poly-gamma-glutamic acid (PGA) as an active ingredient, a composition for maintaining skin elasticity and a composition for improving allergy, wherein each of the compositions contains PGA as an active ingredient. The inventive compositions containing PGA are effective in maintaining skin moisturization and skin elasticity by effectively inhibiting the activity of hyaluronidase which is an enzyme that degrades hyaluronic acid present in the skin dermis. Also, the compositions can relieve allergic symptoms by inhibiting the permeability of inflammatory cells.

Abstract: The present invention relates to a mosquito repellent comprises at least one or more mosquito repelling compound selected from the group consisting of citronellic acid, geranic acid and derivatives thereof in an effective amount to repel mosquitoes.

Abstract: A memory system includes a plurality of memory devices, a controller configured to control the plurality of memory devices, and at least one channel connected between the plurality of memory devices and the controller. The at least one channel includes input/output data lines and control signal lines, which are connected with the plurality of memory devices, and chip enable signal lines respectively connected to each of the plurality of memory devices, wherein the chip enable signal lines enable the plurality of memory devices independently.

Abstract: The present invention relates to an anticoagulant and a composition for preventing thrombus formation, which contain poly-gamma-glutamic acid (PGA) as an active ingredient. The inventive PGA is a water-soluble, anionic, biodegradable and edible amino acid polymer material, which has an anticoagulant effect of preventing thrombi from being accumulated in blood vessels, shows an excellent sustained-release effect and is harmless to the human body. Thus, it is useful as a high-value-added anticoagulant and a food or beverage composition for preventing thrombus formation.

Abstract: A multi-level cell (MLC) memory device may include ‘a’ number of m-bit MLC memory cells; an encoder that encodes ‘k’ bits of data at a code rate of k/n to generate an encoded bit stream; and a signal mapping module that applies pulses to the MLC memory cells in order to write the encoded bit stream in the MLC memory cells. In the device, ‘a’ and ‘m’ may be integers greater than or equal to 2, ‘k’ and ‘n’ may be integers greater than or equal to 1, and ‘n’ may be greater than ‘k’. A method of storing data in the device may include encoding ‘k’ bits of data at a code rate of k/n to generate an encoded bit stream. A method of reading data from the device may include decoding ‘n’ bits of data at a code rate of n/k to generate a decoded bit stream.

Abstract: A multi-level cell (MLC) memory device may include ‘a’ number of m-bit MLC memory cells; an encoder that encodes ‘k’ bits of data at a code rate of k/n to generate an encoded bit stream; and a signal mapping module that applies pulses to the MLC memory cells in order to write the encoded bit stream in the MLC memory cells. In the device, ‘a’ and ‘m’ may be integers greater than or equal to 2, ‘k’ and ‘n’ may be integers greater than or equal to 1, and ‘n’ may be greater than ‘k’. A method of storing data in the device may include encoding ‘k’ bits of data at a code rate of k/n to generate an encoded bit stream. A method of reading data from the device may include decoding ‘n’ bits of data at a code rate of n/k to generate a decoded bit stream.

Abstract: Memory devices and/or error control codes (ECC) decoding methods may be provided. A memory device may include a memory cell array, and a decoder to perform hard decision decoding of first data read from the memory cell array by a first read scheme, and to generate output data and error information of the output data. The memory device may also include and a control unit to determine an error rate of the output data based on the error information, and to determine whether to transmit an additional read command for soft decision decoding to the memory cell array based on the error rate. An ECC decoding time may be reduced through such a memory device.